![](/img/cover-not-exists.png)
P2.13-09 Efficacy and Safety of Osimertinib After Prior EGFR TKI: Analysis of Patients Underrepresented in Randomized Clinical Trials
Araujo, L.H., Castro, G., De Marchi, P., Baldotto, C., Werutsky, G., Borges, G., Mathias, C., Calabrich, A., Costa, C., Franke, F., Lima, E., Neron, Y., Schwartsmann, G., Custodio, M., Sansevero, C.,Volume:
13
Language:
english
Journal:
Journal of Thoracic Oncology
DOI:
10.1016/j.jtho.2018.08.1404
Date:
October, 2018
File:
PDF, 146 KB
english, 2018